Skip to main content

Table 1 Baseline characteristics of the study population

From: Combined use of intravenous and topical tranexamic acid in patients aged over 70 years old undergoing total hip arthroplasty

 

Variable

Combined Group (N = 60)

Single IV Group (N = 60)

Topical Group (N = 60)

p

Demographic characteristics

Age (years)

75.44 ± 4.75

76.34 ± 3.55

75.61 ± 5.27

0.46

Male sex (no. [%] of patients)

34(58%)

27 (45%)

33(55%)

0.51

Weight (kg)

62.68 ± 11.49

57.75 ± 11.32

60.38 ± 9.98

0.08

Height (cm)

162.20 ± 8.45

158.50 ± 9.12

160.74 ± 7.84

0.06

Body mass index (kg/m2)

23.70 ± 3.04

22.95 ± 3.81

22.95 ± 2.21

0.42

Osteonecrosis of femoral head

31

35

33

Osteoarthritis

29

25

27

Preop. laboratory values

Hemoglobin (g/dL)

130.21 ± 14.91

132.57 ± 17.23

131.49 ± 15.68

0.28

Hematocrit (L/L)

0.45 ± 0.05

0.43 ± 0.06

0.44 ± 0.03

0.34

Platelet count (109/L)

178.68 ± 62.43

173.76 ± 51.17

167.12 ± 66.32

0.88

  1. p values indicate that were significantly different between the groups